Conversion from conventional to atypical neuroleptics - recommendations for inpatient and outpatient treatment

被引：0

作者：

Lambert, M ^{[1
]}

Moritz, S ^{[1
]}

Haasen, C ^{[1
]}

Naber, D ^{[1
]}

机构：

[1] Univ Hamburg, Klin Psychiat & Psychotherapie, D-20246 Hamburg, Germany

来源：

NERVENARZT | 2000年 / 71卷 / 11期

关键词：

schizophrenia; conventional antipsychotics; atypical antipsychotics; conversion;

D O I：

10.1007/s001150050677

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The introduction of atypical antipsychotics has presented new options for the pharmacological treatment of schizophrenic patients. It is assumed that in the near future, neuroleptic medication will shift from conventional to atypical antipsychotics for an increasing number of patients. The present article addresses guidelines for the conversion from conventional to atypical neuroleptics in inpatient and outpatient settings.

引用

页码：859 / +

页数：17

共 53 条

[1]

Allison DB, 1999, AM J PSYCHIAT, V156, P1686

[2] Multiple fixed doses of ''Seroquel'' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo [J].

Arvanitis, LA ;

Miller, BG ;

Borison, RL ;

Pitts, WM ;

Sharif, ZA ;

Hamner, MB ;

Herz, MI ;

True, JE ;

Velligan, D ;

Knesevich, MA ;

Small, J ;

Steinbook, R ;

Hertzman, M ;

Keck, PE ;

Newcomer, JW ;

Grace, J ;

Rotrosen, J ;

Tandon, R ;

Dott, SG ;

Ferguson, JM ;

Addington, DEN ;

MacEwan, GW ;

Nair, VNP ;

Shriqui, CL ;

Williams, R ;

Daniel, DG ;

Shehi, GM ;

Patterson, WM ;

Merideth, CH .

BIOLOGICAL PSYCHIATRY, 1997, 42 (04) :233-246

[3]

BACHER N, 1996, BRIT J PSYCHIAT, V168, P529

[4] Olanzapine-induced neutropenia after clozapine-induced neutropenia [J].

Benedetti, F ;

Cavallaro, R ;

Smeraldi, E .

LANCET, 1999, 354 (9178) :567-567

[5] Changing antipsychotic medication: Guidelines on the transition to treatment with risperidone [J].

Borison, RL .

CLINICAL THERAPEUTICS, 1996, 18 (04) :592-607

[6]

Breier AF, 1999, AM J PSYCHIAT, V156, P294

[7] WITHDRAWAL FROM NEUROLEPTIC DRUGS [J].

BROOKS, GW .

AMERICAN JOURNAL OF PSYCHIATRY, 1959, 115 (10) :931-932

[8]

CASEY DE, 1996, EXPERT OPINION INVES, V5, P939

[9]

CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25

[10]

COHEN BM, 1988, ARCH GEN PSYCHIAT, V45, P879

← 1 2 3 4 5 6 →